Ziopharm Oncology Presentation at the Jefferies 2019 London Healthcare Conference to be Webcast

NEXT STORY
Plasma Fractionation Market to Reach USD 38.65 Bn by 2026, Kedrion Biopharma’s FDA Approval to Create Attractive Growth Opportunities: Fortune Business Insights
PREV STORY
Selecta Biosciences Presents New Data at 2019 American College of Rheumatology Annual Meeting from Phase 2 Study of SEL-212 for the Treatment of Patients with Chronic Refractory Gout
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aptose to Hold Corporate Update Monday, December 13th

author_avatar
NASDAQ Market News

OPEP Device For COPD Symptom Relief – AirPhysio Lung Expansion Product Launched

author_avatar
NASDAQ Market News

Second wave of kids with MIS-C had more severe illness than first wave, according to new Children’s National Hospital study

author_avatar
NASDAQ Market News